Mixwell Focus: Kinesiology & The Neuropathic Path to Recovery
In contact sports, injuries are often categorized by visible trauma—bruises, sprains, or fractures. However, for many athletes, the most debilitating injuries are those that affect the nervous system. Kinesiology, the study of human movement, highlights how nerve dysfunction can lead to "short-circuited" motor patterns, muscle weakness, and chronic burning sensations.
One of the most common neurological events in contact sports is the "Stinger" or "Burner." This injury occurs when the brachial plexus—the network of nerves that sends signals from your spinal cord to your shoulder, arm, and hand—is suddenly stretched or compressed. While many stingers resolve quickly, they can often lead to lingering neuropathic pain that sidelines an athlete long after the initial impact.
The Challenge of Oral Neuropathic Medications
Managing nerve pain in active individuals presents a unique clinical challenge. Standard oral medications for neuropathy (such as anticonvulsants or muscle relaxants) often carry systemic side effects like sedation, dizziness, and delayed reaction times. For an athlete, these side effects can be as detrimental to performance as the injury itself.
To address this, modern sports compounding utilizes Permeation-Enhanced Topical Therapy (PETPT). By delivering active ingredients directly to the site of nerve trauma, we can achieve high local concentrations while minimizing the systemic "fog" associated with oral pills.
Technical Spotlight: The Multimodal Lipoderm® Approach
The skin is designed to keep substances out. To reach the peripheral nerves, a specialized vehicle is required. PCCA Lipoderm® is the industry-standard permeation-enhancing base, scientifically proven in peer-reviewed studies to deliver up to four active pharmaceutical ingredients (APIs) simultaneously through the skin.
Technical Verbiage: Common PCCA Applications for Sports Neuropathy
In the field of Kinesiology and sports medicine, clinicians often utilize specific multimodal combinations to target different nerve pathways simultaneously:
-
PCCA Formula commonly used for: Ketamine HCl / Gabapentin / Baclofen in Lipoderm®.
- Ketamine: Acts as an NMDA-receptor antagonist to help block "wind-up" pain and central sensitization.
- Gabapentin: Targets calcium channels to dampen overactive nerve signaling (neuropathic fire).
- Baclofen: A GABAB agonist used to address the localized muscle spasticity that often accompanies nerve "stinger" injuries.
- PCCA Formula commonly used for: Ketoprofen / Cyclobenzaprine / Lidocaine combinations to manage the inflammatory and muscular components of a brachial plexus injury alongside the neuropathic symptoms.
Clinical & Legal References (PCCA)
- PCCA Science Study: Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, and Baclofen in Lipoderm®
- PCCA Blog: Permeation-Enhanced Topical Pain Therapy: A Literature Review
- PCCA Clinical Resource: Pharmaceutical Considerations in Treating Neuropathic Pain in Athletes
- PCCA Technology: Lipoderm®: The Standard in Permeation-Enhancing Bases
Want to learn more?
Call Mixwell at 909-378-7301